Correlation Between NewAmsterdam Pharma and Neurobo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on NewAmsterdam Pharma and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Neurobo Pharmaceuticals.

Diversification Opportunities for NewAmsterdam Pharma and Neurobo Pharmaceuticals

0.4

Correlation Coefficient

NewAmsterdam Pharma  Neurobo Pharmaceuticals

Very weak diversification

The 3 months correlation between NewAmsterdam and Neurobo is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Neurobo Pharmaceuticals go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Neurobo Pharmaceuticals

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.01 times more return on investment than Neurobo Pharmaceuticals. However, NewAmsterdam Pharma is 1.01 times more volatile than Neurobo Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  2,080  in NewAmsterdam Pharma on November 27, 2024 and sell it today you would lose (292.00) from holding NewAmsterdam Pharma or give up 14.04% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	71.19%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Neurobo Pharmaceuticals

NewAmsterdam Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Neurobo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with NewAmsterdam Pharma and Neurobo Pharmaceuticals

The main advantage of trading using opposite NewAmsterdam Pharma and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.

The idea behind NewAmsterdam Pharma and Neurobo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.